Browse by author
Lookup NU author(s): Anna Dehghanizai, Professor Christopher StewartORCiD, Dr Rhys ThomasORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.The gastrointestinal tract is inhabited by trillions of micro-organisms that form the gut microbiome, which serves various functions that can influence neurological pathways. It can release metabolites that could affect the nervous system. The bidirectional communication between the intestine and the central nervous system is known as the gut-brain axis. This communication can be impacted by the microbiota in various direct and indirect ways. There has been a suggested connection between the microbiome and many neurological disorders, including epilepsy, Alzheimer's disease, Parkinson's disease and multiple sclerosis. This has been explored in human and animal studies. While no microbial biomarkers have been identified yet, alterations in several taxa have been suggested to be associated with disease states. The potential of the microbiome to modulate neurological function has sparked multiple clinical trials using gut-altering treatments, some with positive preliminary results.
Author(s): Dehghanizai AB, Stewart CJ, Thomas RH
Publication type: Article
Publication status: Published
Journal: Practical Neurology
Year: 2025
Pages: epub ahead of print
Online publication date: 12/03/2025
Acceptance date: 27/01/2025
ISSN (print): 1474-7758
ISSN (electronic): 1474-7766
Publisher: BMJ Publishing Group
URL: https://doi.org/10.1136/pn-2024-004400
DOI: 10.1136/pn-2024-004400
Altmetrics provided by Altmetric